Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06343285 · ClinicalTrials.gov registry record · NA
Upper Limb Tremor Reduction in Essential Tremor Patients
A NA study, sponsored by Encora.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT06343285 is a NA study that has completed, run by Encora. The registered enrollment target is 71 participants.
The verdict
NCT06343285, a NA study, has completed, sponsored by Encora.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study is designed to demonstrate the safety, tolerability, and efficacy of the Encora Therapeutics Tremor Mitigation Device in subjects with upper limb tremor caused by Essential Tremor.
Interventions
- DEVICE Encora Therapeutics Tremor Reduction Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2024-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06343285
The ClinicalTrials.gov registry entry for NCT06343285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Encora, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Encora Therapeutics Tremor Reduction Device is the first listed.
NCT06343285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06343285 about?
NCT06343285 is a clinical study titled "Upper Limb Tremor Reduction in Essential Tremor Patients". This study is designed to demonstrate the safety, tolerability, and efficacy of the Encora Therapeutics Tremor Mitigation Device in subjects with upper limb tremor caused by Essential Tremor.
What is the current status of trial NCT06343285?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2024-01-01. Estimated completion is 2024-11-12.
What interventions are being tested in trial NCT06343285?
The interventions under investigation include: Encora Therapeutics Tremor Reduction Device (DEVICE).
Who is sponsoring clinical trial NCT06343285?
This trial is sponsored by Encora, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.